Type 2 & other diabetes

Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease

Diabetes MetabPublished Systematic analysis of the Global Burden of Disease 2021 study

Authors' conclusion

This study on the burden of T2D reveals that its prevalence among non-elderly individuals is steadily increasing and is projected to affect over a billion people worldwide by 2050. Targeted measures are crucial to tackle this global health challenge for this population.

Study context

Population
Individuals aged 15 to 59 across 204 countries and regions, 21 Global Burden of Disease (GBD) regions by Sociodemographic Index (SDI), 1990–2021204 countries and regions
Outcome
Global age-standardized incidence rate of T2D
Follow-up
1990 to 2021
Methodological detailsjoin-point regression, Bayesian Age-Period-Cohort models, projections to 2050
  • Join-point regression
  • Bayesian Age-Period-Cohort models
  • Projections to 2050

Main finding

As reported in the abstract

Age-standardized incidence rate in 1990

196.3 per 100,000

95% UI 145.2–257.4

Age-standardized incidence rate in 2021

361.1 per 100,000

95% UI 275.2–458.4

Observational data: associations, not effects.

Further findings

Sex, SDI and risk factors

Men lead prevalence, incidence, mortality rate and Disability-Adjusted Life Years (DALYs) across nearly all age groups
Low-middle SDI countries bear the most severe disease burden
High BMI is a major risk factor

Projected non-elderly individuals with T2D · 2050

Approximately, worldwide; epidemiological changes the primary driver
1.195 billion

Original publication

Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease. Diabetes Metab. Published 8 May 2025. doi:10.1016/j.diabet.2025.101660

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.